Literature DB >> 9844041

Mapping of topoisomerase II alpha epitopes recognized by autoantibodies in idiopathic pulmonary fibrosis.

B Grigolo1, I Mazzetti, R M Borzì, I D Hickson, M Fabbri, L Fasano, R Meliconi, A Facchini.   

Abstract

Autoantibodies against DNA topoisomerase II alpha have been identified in the sera of patients with idiopathic pulmonary fibrosis (IPF). To map topoisomerase II autoepitopes, we tested by ELISA and immunoblotting the IPF anti-topoisomerase II-positive sera against a series of recombinant proteins which covered the full length of topoisomerase II alpha. Specific patterns of reactivity were observed, indicating the existence of multiple epitopes on topoisomerase II, either highly complex or conformational/discontiguous or conformational/contiguous ones. The latter resided in amino acid residues 854-1147 and 1370-1447. A detailed analysis of these regions was undertaken, but we were not able to pinpoint a sequential peptide-sized epitope, or any significant homology with foreign pathogens. Further, we observed a significant correlation between the progression from a contiguous to a quaternary/tertiary structure-dependent autoepitope and the disease duration but not with the disease severity. Therefore, this result supports the hypothesis that anti-topoisomerase II autoreactivity evolves following an antigen-driven process.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9844041      PMCID: PMC1905127          DOI: 10.1046/j.1365-2249.1998.00747.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  45 in total

1.  Basic local alignment search tool.

Authors:  S F Altschul; W Gish; W Miller; E W Myers; D J Lipman
Journal:  J Mol Biol       Date:  1990-10-05       Impact factor: 5.469

2.  Prediction of protein antigenic determinants from amino acid sequences.

Authors:  T P Hopp; K R Woods
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

3.  Effect of lung T lymphocytes on fibroblasts in idiopathic pulmonary fibrosis and extrinsic allergic alveolitis.

Authors:  M Selman; G Gonzalez; M Bravo; J Sullivan-Lopez; C Ramos; M Montano; N Barquin; F Vadillo
Journal:  Thorax       Date:  1990-06       Impact factor: 9.139

4.  Mapping of B cell epitopes on small nuclear ribonucleoproteins that react with human autoantibodies as well as with experimentally-induced mouse monoclonal antibodies.

Authors:  W J Habets; M H Hoet; B A De Jong; A Van der Kemp; W J Van Venrooij
Journal:  J Immunol       Date:  1989-10-15       Impact factor: 5.422

5.  Determination of an epitope of the diffuse systemic sclerosis marker antigen DNA topoisomerase I: sequence similarity with retroviral p30gag protein suggests a possible cause for autoimmunity in systemic sclerosis.

Authors:  G G Maul; S A Jimenez; E Riggs; D Ziemnicka-Kotula
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

6.  Mechanism of inhibition of DNA gyrase by analogues of nalidixic acid: the target of the drugs is DNA.

Authors:  L L Shen; A G Pernet
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

7.  Autoantibodies to DNA topoisomerase II in cryptogenic fibrosing alveolitis and connective tissue disease.

Authors:  R Meliconi; M Bestagno; C Sturani; C Negri; V Galavotti; C Sala; A Facchini; G Ciarrocchi; G Gasbarrini; G C Astaldi Ricotti
Journal:  Clin Exp Immunol       Date:  1989-05       Impact factor: 4.330

8.  Mechanism of antitumor drug action: poisoning of mammalian DNA topoisomerase II on DNA by 4'-(9-acridinylamino)-methanesulfon-m-anisidide.

Authors:  E M Nelson; K M Tewey; L F Liu
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

9.  Identification of DNA topoisomerase II as an intracellular target of antitumor epipodophyllotoxins in simian virus 40-infected monkey cells.

Authors:  L Yang; T C Rowe; L F Liu
Journal:  Cancer Res       Date:  1985-11       Impact factor: 12.701

10.  Insights into native epitopes of proliferating cell nuclear antigen using recombinant DNA protein products.

Authors:  J P Huff; G Roos; C L Peebles; R Houghten; K F Sullivan; E M Tan
Journal:  J Exp Med       Date:  1990-08-01       Impact factor: 14.307

View more
  7 in total

1.  Anti-topoisomerase II alpha autoantibodies in systemic sclerosis-association with pulmonary hypertension and HLA-B35.

Authors:  B Grigolo; I Mazzetti; R Meliconi; S Bazzi; R Scorza; M Candela; A Gabrielli; A Facchini
Journal:  Clin Exp Immunol       Date:  2000-09       Impact factor: 4.330

2.  Analysis of the autoimmune epitopes on human testicular NASP using recombinant and synthetic peptides.

Authors:  I N Batova; R T Richardson; E E Widgren; M G O'Rand
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

3.  A critical role for alveolar macrophages in elicitation of pulmonary immune fibrosis.

Authors:  J Zhang-Hoover; A Sutton; N van Rooijen; J Stein-Streilein
Journal:  Immunology       Date:  2000-12       Impact factor: 7.397

4.  Plasma B lymphocyte stimulator and B cell differentiation in idiopathic pulmonary fibrosis patients.

Authors:  Jianmin Xue; Daniel J Kass; Jessica Bon; Louis Vuga; Jiangning Tan; Eva Csizmadia; Leo Otterbein; Makoto Soejima; Marc C Levesque; Kevin F Gibson; Naftali Kaminski; Joseph M Pilewski; Michael Donahoe; Frank C Sciurba; Steven R Duncan
Journal:  J Immunol       Date:  2013-07-19       Impact factor: 5.422

5.  Patients with idiopathic pulmonary fibrosis with antibodies to heat shock protein 70 have poor prognoses.

Authors:  Rehan A Kahloon; Jianmin Xue; Arpit Bhargava; Eva Csizmadia; Leo Otterbein; Daniel J Kass; Jessica Bon; Makoto Soejima; Marc C Levesque; Kathleen O Lindell; Kevin F Gibson; Naftali Kaminski; Gunjan Banga; Chester V Oddis; Joseph M Pilewski; Frank C Sciurba; Michael Donahoe; Yingze Zhang; Steven R Duncan
Journal:  Am J Respir Crit Care Med       Date:  2013-04-01       Impact factor: 21.405

Review 6.  Determinants of initiation and progression of idiopathic pulmonary fibrosis.

Authors:  Robert Matthew Kottmann; Christopher M Hogan; Richard P Phipps; Patricia J Sime
Journal:  Respirology       Date:  2009-09       Impact factor: 6.424

7.  Private specificities can dominate the humoral response to self-antigens in patients with cryptogenic fibrosing alveolitis.

Authors:  C Robinson; M Callow; S Stevenson; B W Robinson; R A Lake
Journal:  Respir Res       Date:  2001-02-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.